M. Catherine Lee, MD, FACS

Where You Are:
M. Catherine Lee, MD, FACS

Associate Member

Office  (813) 745-8410

Education And Training
  • Fellow, University of Michigan Cancer Center, 2007 - Surgical Breast Oncology
  • Chief Resident, Lenox Hill Hospital, 2006 - General Surgery
  • Resident, Lenox Hill Hospital, 2005 - General Surgery
  • MD, Northeastern Ohio Universities College of Medicine, 2001


In addition to retrospective studies, Dr. Lee is currently co-investigator on a recently funded R21 with Dr. Susan Vadaparampil which seeks to improve genetic counseling services for patients recently diagnosed with breast cancer. She also is actively involved with her colleagues in investigating and improving fertility preservation education for providers and patients; these efforts have resulted in accepted abstracts to the ASCO 2012 National Meeting and the American Society for Reproductive Medicine. She also is collaborating with the faculty in Molecular and Functional Imaging in the development of novel agents for intraoperative identification of breast cancer. And finally, she is the primary investigator for two ongoing clinical trials, one investigator-initiated project examining 3D ultrasound for breast cancer patients, and another industry-sponsored  phase 0 trial examining novel agents in breast cancer. Her other research focus is primarily translational; she has had one grant-funded project examining early biomarkers for breast cancer and continues to actively seek external funding for this and other translational projects.

  • Lee MC, Laronga C. The pregnant breast cancer patient: are we failing our most vulnerable population?. Ann Surg Oncol. 2014 Aug;21(8):2474-2475. Pubmedid: 24743913.
  • Goble RN, Drukteinis JS, Lee MC, Khakpour N, Kiluk JV, Laronga C. Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer. J Surg Oncol. 2014 Jun;109(8):751-755. Pubmedid: 24862923.
  • Kiluk JV, Prowler V, Lee MC, Khakpour N, Laronga C, Cox CE. Contralateral axillary nodal involvement from invasive breast cancer. Breast. 2014 Jun;23(3):291-294. Pubmedid: 24709584.
  • Prowler VL, Joh JE, Acs G, Kiluk JV, Laronga C, Khakpour N, Lee MC. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy. Breast. 2014 Feb. Pubmedid: 24518220.
  • Lee MC, Bhati RS, von Rottenthaler EE, Reagan AM, Karver SB, Reich RR, Quinn GP. Therapy choices and quality of life in young breast cancer survivors: a short-term follow-up. Am J Surg. 2013 Nov;206(5):625-631. Pubmedid: 24016705.
  • Williams M, Eatrides J, Kim J, Talwar H, Esposito N, Szabunio M, Ismail-Khan R, Kiluk J, Lee M, Laronga C, Khakpour N. Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy. Am J Surg. 2013 Oct;206(4):567-573. Pubmedid: 23809673.
  • Walsh N, Greene J, Catherine Lee M. Tuberculous adenopathy masquerading as locally advanced breast cancer. Breast J. 2013 Jan;19(1):106-107. Pubmedid: 23279334.
  • Joh JE, Han G, Kiluk JV, Laronga C, Khakpour N, Lee MC. Indications for axillary ultrasound use in breast cancer patients. Clin Breast Cancer. 2012 Dec;12(6):433-437. Pubmedid: 23062709.
  • Joh JE, Esposito NN, Kiluk JV, Laronga C, Khakpour N, Soliman H, Catherine Lee M. Pathologic Tumor Response of Invasive Lobular Carcinoma to Neo-adjuvant Chemotherapy. Breast J. 2012 Nov;18(6):569-574. Pubmedid: 23034096.
  • Lee MC, Joh JE, Chau A. Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography. Cancer Control. 2012 Oct;19(4):277-285. Pubmedid: 23037495.
  • Walsh N, Kiluk JV, Sun W, Khakpour N, Laronga C, Lee MC. Ipsilateral nodal recurrence after axillary dissection for breast cancer. J Surg Res. 2012 Sep;177(1):81-86. Pubmedid: 22498028.
  • Lee MC, Plews R, Rawal B, Kiluk JV, Loftus L, Laronga C. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review. Ann Surg Oncol. 2012 Jun;19(6):1818-1824. Pubmedid: 22203185.
  • Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, Soliman H, Boughey JC, Reynolds C, Lawton TJ, Acs PI, Gordan L, Acs G. The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. Oncologist. 2012 Jun;16(11):1520-1526. Pubmedid: 22016474. Pmcid: PMC3233285.
  • Turaga KK, Chau A, Eatrides JM, Kiluk JV, Khakpour N, Laronga C, Lee MC. Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist. 2012 Jan;16(7):942-948. Pubmedid: 21572122. Pmcid: PMC3228129.
  • Doren EL, Parikh RP, Laronga C, Hiro ME, Sun W, Lee MC, Smith PD, Fulp WJ. Sequelae of fat grafting postmastectomy: an algorithm for management of fat necrosis. Eplasty. 2012;12:e53. Pubmedid: 23308300. Pmcid: PMC3516285.
  • Pimiento JM, Gadgil PV, Santillan AA, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Hartley TL, Yeh IT, Laronga C. Phyllodes tumors: race-related differences. J Am Coll Surg. 2011 Oct;213(4):537-542. Pubmedid: 21856184.
  • Kiluk JV, Lee MC, Park CK, Meade T, Minton S, Harris E, Kim J, Laronga C. Male Breast Cancer: Management and Follow-up Recommendations. Breast J. 2011 Sep;17(5):503-509. Pubmedid: 21883641.
  • Pimiento JM, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Carter WB, Han G, Laronga C. Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. J Oncol Pract. 2011 Sep;7(5):309-313. Pubmedid: 22211128. Pmcid: PMC3170064.
  • Kiluk JV, Khakpour N, Lee MC, Lowe J, Harris E, Szabunio M, Laronga C. Management of abnormal Rotter's lymph nodes identified on preoperative breast magnetic resonance imaging. Am Surg. 2011 Jan;77(1):E10-E12. Pubmedid: 21396292.
  • Lee MC, Eatrides J, Chau A, Han G, Kiluk JV, Khakpour N, Cox CE, Carter WB, Laronga C. Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers. Ann Surg Oncol. 2011 Jan;18(1):72-77. Pubmedid: 20585876.
  • Lee MC, Gray J, Han HS, Plosker S. Fertility and reproductive considerations in premenopausal patients with breast cancer. Cancer Control. 2010 Jul;17(3):162-172. Pubmedid: 20664513.
  • Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, Cox CE. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009 Dec;209(6):746-752. Pubmedid: 19959044.
  • Lee MC, Kilbride KE. Timing of Axillary Staging. Ann Surg Oncol. 2009 Apr;16(4):1065-1065. Pubmedid: 19198950.
  • Lee M, Rogers K, Griffith K, Diehl K, Breslin T, Cimmino V, Chang A, Newman L, Sabel M. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009 Jan;15(1):34-40. Pubmedid: 19141132.
  • Lee M, Jagsi R. Postmastectomy radiation therapy: indications and controversies. Surg Clin North Am. 2007 Apr;87(2):511-526. Pubmedid: 17498541.
  • Lee M, Newman L. Management of patients with locally advanced breast cancer. Surg Clin North Am. 2007 Apr;87(2):379-398. Pubmedid: 17498533.
  • Chorost M, Lee M, Yeoh C, Molina M, Ghosh B. Unknown primary. J Surg Oncol. 2004 Sep;87(4):191-203. Pubmedid: 15334635.
  • Lee M, Lehman JA J, Tantri M, Parker M, Wagner D. Bilateral reduction mammoplasty in an adolescent population: adolescent bilateral reduction mammoplasty. J Craniofac Surg. 2003 Sep;14(5):691-695. Pubmedid: 14501330.
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer